CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,408,085 | -4.6% | 88,706 | -42.5% | 0.01% | -10.0% |
| Q1 2023 | $3,571,235 | -1.7% | 154,265 | +11.3% | 0.01% | -9.1% |
| Q4 2022 | $3,632,054 | -16.4% | 138,628 | -37.3% | 0.01% | -26.7% |
| Q3 2022 | $4,344,000 | +13.8% | 220,945 | +1.2% | 0.02% | +15.4% |
| Q2 2022 | $3,818,000 | +1039.7% | 218,283 | +965.7% | 0.01% | +1200.0% |
| Q1 2022 | $335,000 | -90.3% | 20,482 | -90.3% | 0.00% | -85.7% |
| Q4 2021 | $3,451,000 | -16.6% | 211,592 | -34.8% | 0.01% | -22.2% |
| Q3 2021 | $4,140,000 | +222.2% | 324,445 | +256.5% | 0.01% | +200.0% |
| Q2 2021 | $1,285,000 | +381.3% | 90,997 | +429.6% | 0.00% | +200.0% |
| Q1 2021 | $267,000 | -74.9% | 17,182 | -74.4% | 0.00% | -66.7% |
| Q4 2020 | $1,065,000 | – | 67,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |